DAVIDSON BEVERLY L has a total of 18 patent applications. Its first patent ever was published in 2002. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are CHANG LUNG-JI, GENERATION BIO CO and BLUE SKY VACCINES GMBH.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 13 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Australia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Agriculture | |
#5 | Foods and drinks | |
#6 | Measurement |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Animal care | |
#5 | Climate change adaptation technologies | |
#6 | Peptides | |
#7 | Enzymes | |
#8 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Davidson Beverly L | 18 |
#2 | Paulson Henry | 5 |
#3 | Harper Scott | 5 |
#4 | Mas Monteys Alejandro | 4 |
#5 | Boudreau Ryan | 3 |
#6 | Miller Victor | 3 |
#7 | Boudreau Ryan L | 3 |
#8 | Law Lane K | 2 |
#9 | Xia Haibin | 2 |
#10 | Mcbride Jodi L | 2 |
Publication | Filing date | Title |
---|---|---|
US2011244561A1 | SiRNA-mediated gene silencing | |
US2011111491A1 | RNA interference suppresion of neurodegenerative diseases and methods of use thereof | |
US2008176812A1 | Allele-specific silencing of disease genes | |
US2005255086A1 | Nucleic acid silencing of Huntington's Disease gene | |
WO2005038035A2 | Methods for producing and using in vivo pseudotyped retroviruses | |
WO03035849A2 | Methods for gene transfer using pseudotyped lentiviruses | |
AU2002314705A1 | Adenovirus serotype 30 (ad30) fiber protein and uses thereof |